Chargement de la fiche…
Chargement de la fiche…
MonRhumato.fr utilise des cookies pour mesurer l'audience (statistiques) et améliorer le site. Aucune donnée de santé identifiable n'est jamais collectée. Politique de confidentialité.
Votre choix est conservé 13 mois (durée max CNIL). Vous pouvez le modifier à tout moment via Préférences cookies.
2 raisons identifiées
Auteur de référence en rhumatologie
50 articles scientifiques publiés — un praticien à la pointe de la recherche
Délais de RDV courts dans la région
336.2 rhumatos / 100 000 hab. — département bien doté
✨ Génération du profil synthétique IA en cours…
Indicateurs publics agrégés sur 250 M+ d'œuvres scientifiques (OpenAlex, PubMed). Traduits ici en langage patient.
Influence scientifique
Données ANS publiques (Licence Ouverte 2.0) · Enrichissements MonRhumato 100 % opt-in · Toute personne référencée peut demander la suppression ou la rectification.
54
54 articles ont été cités au moins 54fois par d'autres chercheurs — preuve que ses travaux sont repris par la communauté médicale.
h-index
Total citations reçues
9 916
Nombre de fois où d'autres équipes ont mentionné ses publications dans leurs propres travaux.
Publications totales
222
Articles, revues et chapitres référencés dans les bases académiques internationales.
Articles influents
127
Publications ayant marqué leur domaine — chacune citée au moins 10 fois par d'autres chercheurs.
i10-index
Thématiques principales
Affiliations FR : Sorbonne Université · Assistance Publique – Hôpitaux de Paris · Hôpital Tenon
Source : OpenAlex (CC0, OurResearch). Indicateurs académiques agrégés sur 250 M+ d'œuvres.
Articles déposés en accès libre sur l'archive ouverte des universités françaises (HAL) — gage d'activité de recherche en France.
Interferon-α biological activity is associated with disease activity and risk of flare in cutaneous lupus erythematosus: a monocentric study of 184 patients
2025ArticleJournal of the American Association of Dermatology
Development of the 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria, Phase III‐D Report: Multicriteria Decision Analysis
2024ArticleArthritis Care and Research
2023 ACR/EULAR antiphospholipid syndrome classification criteria
2023ArticleAnnals of the Rheumatic Diseases
The 2023 ACR / EULAR Antiphospholipid Syndrome Classification Criteria
2023ArticleArthritis & rheumatology
Cutaneous vasculitis occurring in the setting of systemic lupus erythematosus: a multicentre cohort study
2023ArticleRheumatology
Risk factors of progression from discoid lupus to severe systemic lupus erythematosus: a registry-based cohort study of 164 patients.
2023ArticleJournal of The American Academy of Dermatology
Prevalence and factors associated with long-term remission in cutaneous lupus: A longitudinal cohort study of 141 cases
2022ArticleJournal of The American Academy of Dermatology
Male sex, discoid lupus erythematosus, and lower limb involvement are associated with systemic lupus in lupus panniculitis patients: A multicenter case series of 74 patients
2022ArticleJournal of The American Academy of Dermatology
Source : HAL — archive ouverte CCSD/CNRS (couvre articles, chapitres EMC, communications congrès, thèses).
DOCTEUR CLAIRE GEOFFRAY
64 RUE PIERRE DEMOURS, 75017 PARIS
Secteur de conventionnement non disponible (médecin hospitalier ou non présent dans l'Annuaire santé CNAM des libéraux conventionnés).
Lien Doctolib = recherche Google site:doctolib.fr (le 1er résultat est presque toujours le profil correct s'il existe).
Arthritis & rheumatology (Hoboken, N.J.) · 2023
ObjectiveTo develop new antiphospholipid syndrome (APS) classification criteria with high specificity for use in observational studies and trials, jointly supported by the American College of Rheumatology (ACR) and EULAR.MethodsThis international multidisciplinary initiative included 4 phases: 1) Phase I, criteria generation by surveys and literature review; 2) Phase II, criteria reduction by modified Delphi and nominal group technique exercises; 3) Phase III, criteria definition, further reduction with the guidance of real‐world patient scenarios, and weighting via consensus‐based multicriteria decision analysis, and threshold identification; and 4) Phase IV, validation using independent adjudicators’ consensus as the gold standard.ResultsThe 2023 ACR/EULAR APS classification criteria include an entry criterion of at least one positive antiphospholipid antibody (aPL) test within 3 years of identification of an aPL‐associated clinical criterion, followed by additive weighted criteria (score range 1–7 points each) clustered into 6 clinical domains (macrovascular venous thromboembolism, macrovascular arterial thrombosis, microvascular, obstetric, cardiac valve, and hematologic) and 2 laboratory domains (lupus anticoagulant functional coagulation assays, and solid‐phase enzyme‐linked immunosorbent assays for IgG/IgM anticardiolipin and/or IgG/IgM anti–β2‐glycoprotein I antibodies). Patients accumulating at least 3 points each from the clinical and laboratory domains are classified as having APS. In the validation cohort, the new APS criteria versus the 2006 revised Sapporo classification criteria had a specificity of 99% versus 86%, and a sensitivity of 84% versus 99%.ConclusionThese new ACR/EULAR APS classification criteria were developed using rigorous methodology with multidisciplinary international input. Hierarchically clustered, weighted, and risk‐stratified criteria reflect the current thinking about APS, providing high specificity and a strong foundation for future APS research.
Annals of the rheumatic diseases · 2023
Arthritis & rheumatology (Hoboken, N.J.) · 2018
ObjectiveTo prepare a dermatologic addendum to the 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides (CHCC2012) to address vasculitides affecting the skin (D‐CHCC). The goal was to standardize the names and definitions for cutaneous vasculitis.MethodsA nominal group technique with a facilitator was used to reach consensus on the D‐CHCC nomenclature, using multiple face‐to‐face meetings, e‐mail discussions, and teleconferences.ResultsStandardized names, definitions, and descriptions were adopted for cutaneous components of systemic vasculitides (e.g., cutaneous IgA vasculitis as a component of systemic IgA vasculitis), skin‐limited variants of systemic vasculitides (e.g., skin‐limited IgA vasculitis, drug‐induced skin‐limited antineutrophil cytoplasmic antibody–associated vasculitis), and cutaneous single‐organ vasculitides that have no systemic counterparts (e.g., nodular vasculitis). Cutaneous vasculitides that were not included in the CHCC2012 nomenclature were introduced.ConclusionStandardized names and definitions are a prerequisite for developing validated classification and diagnostic criteria for cutaneous vasculitis. Accurate identification of specifically defined variants of systemic and skin‐limited vasculitides requires knowledgeable integration of data from clinical, laboratory, and pathologic studies. This proposed nomenclature of vasculitides affecting the skin, the D‐CHCC, provides a standard framework both for clinicians and for investigators.
Source PubMed · Recherche par auteur (homonymes possibles, vérifier l'affiliation).
Journal of the American Academy of Dermatology · 2025 · Journal Article
Murat de Montai Q, Masseran C, Perray L, Mathian A, et al.
Journal of the American Academy of Dermatology · 2024 · Journal Article
Masseran C, Perray L, Murat de Montai Q, Mathian A, et al.
Rheumatology (Oxford, England) · 2023 · Multicenter Study
Breillat P, Jachiet M, Ditchi Y, Lenormand C, et al.
Journal of the American Academy of Dermatology · 2023 · Journal Article
Fredeau L, Courvoisier DS, Ait Mehdi R, Ingen-Housz-Oro S, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV · 2023 · Letter
Jaume L, Fayard D, Breillat P, Francès C, et al.
Journal of the American Academy of Dermatology · 2022 · Journal Article
Lemasson J, Frumholtz L, Jachiet M, Lenormand C, et al.
Journal of the American Academy of Dermatology · 2022 · Journal Article
Sonigo G, Jachiet M, Bessis D, Cordel N, et al.
Annales de dermatologie et de venereologie · 2021 · Journal Article
Bataille P, Chasset F, Monfort JB, De Risi-Pugliese T, et al.
Lupus · 2021 · Journal Article
Monfort JB, Chasset F, Barbaud A, Frances C, et al.
Journal of the American Academy of Dermatology · 2021 · Journal Article
Aitmehdi R, Arnaud L, Francès C, Senet P, et al.
Annales de dermatologie et de venereologie · 2020 · Journal Article
Wagner C, Chasset F, Francès C, Lipsker D
Rheumatology (Oxford, England) · 2020 · Journal Article
Lenfant T, Salah S, Leroux G, Bousquet E, et al.
Dermatologic therapy · 2020 · Letter
Brehon A, Moguelet P, Guégan S, Abisror N, et al.
Journal of immunology research · 2019 · Journal Article
Abuaf N, Desgruelles C, Moumaris M, Boussa-Khettab F, et al.
Drugs · 2019 · Journal Article
Chasset F, Francès C
Seminars in arthritis and rheumatism · 2018 · Journal Article
de Risi-Pugliese T, Cohen Aubart F, Haroche J, Moguelet P, et al.
Journal of the American Academy of Dermatology · 2018 · Journal Article
Cesbron E, Bessis D, Jachiet M, Lipsker D, et al.
Journal of the American Academy of Dermatology · 2018 · Journal Article
Chasset F, Tounsi T, Cesbron E, Barbaud A, et al.
Journal of the American Academy of Dermatology · 2023 · Multicenter Study
Zuelgaray E, Chevret S, Jachiet M, Cacoub P, et al.
Journal of clinical medicine · 2022 · Journal Article
Trefond L, Frances C, Costedoat-Chalumeau N, Piette JC, et al.
Current rheumatology reports · 2025 · Journal Article
Barbhaiya M, Zuily S, Amigo MC, Avcin T, et al.
Arthritis care & research · 2024 · Journal Article
Barbhaiya M, Zuily S, Amigo MC, Andrade D, et al.
Annals of the rheumatic diseases · 2023 · Journal Article
Barbhaiya M, Zuily S, Naden R, Hendry A, et al.
Journal of the American Academy of Dermatology · 2022 · Journal Article
Sonigo G, Jachiet M, Bessis D, Cordel N, et al.
Rheumatology (Oxford, England) · 2020 · Journal Article
Lenfant T, Salah S, Leroux G, Bousquet E, et al.
Annales de dermatologie et de venereologie · 2018 · Journal Article
Tétu P, Hamelin A, Lebrun-Vignes B, Soria A, et al.
International journal of dermatology · 2021 · Letter
Hamann P, Moguelet P, Chasset F, Delaleu J, et al.
Dermatologic therapy · 2020 · Case Reports
Aitmehdi R, Moguelet P, Godot S, Chazerain P, et al.
Journal of the American Academy of Dermatology · 2022 · Journal Article
Fayard D, Francès C, Amoura Z, Breillat P, et al.
Leukemia & lymphoma · 2018 · Journal Article
Jachiet V, Mekinian A, Carrat F, Grignano E, et al.
Journal of the American Academy of Dermatology · 2019 · Letter
de Risi-Pugliese T, Seksik P, Bouaziz JD, Chasset F, et al.
Arthritis & rheumatology (Hoboken, N.J.) · 2018 · Journal Article
Sunderkötter CH, Zelger B, Chen KR, Requena L, et al.
Journal of the American Academy of Dermatology · 2020 · Journal Article
Traineau H, Aggarwal R, Monfort JB, Senet P, et al.
Clinical rheumatology · 2021 · Journal Article
Cassius C, Seta V, Monfort JB, Baudot NA, et al.
Lupus · 2021 · Journal Article
Lalevée S, Moguelet P, Hurabielle C, Senet P, et al.
Mycoses · 2021 · Journal Article
Moreno-Sabater A, Ouali N, Chasset F, Frances C, et al.
Blood · 2020 · Journal Article
Mahévas T, Arnulf B, Bouaziz JD, Livideanu CB, et al.
Journal of the American Academy of Dermatology · 2020 · Letter
Salle R, Chasset F, Kottler D, Picard-Dahan C, et al.
Journal of the American Academy of Dermatology · 2020 · Letter
Chasset F, Fayand A, Moguelet P, Kouby F, et al.
Journal of the American Academy of Dermatology · 2020 · Journal Article
Galezowski A, Delyon J, Le Cleach L, Guégan S, et al.
International journal of dermatology · 2020 · Letter
Delaleu J, Grynberg-Laloum E, Moguelet P, Hamann P, et al.
Journal of the American Academy of Dermatology · 2019 · Journal Article
Delyon J, Rabate C, Euvrard S, Harwood CA, et al.
Joint bone spine · 2019 · Journal Article
Mertz P, Belot A, Cervera R, Chuah TY, et al.
Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology · 2019 · Letter
Seta V, Gaouar H, Badaoui A, Francès C, et al.
Acta dermato-venereologica · 2018 · Journal Article
Gardette E, Moguelet P, Bouaziz JD, Lipsker D, et al.
JAAD case reports · 2018 · Case Reports
de Masson A, Frumholtz L, Battistella M, Vignon-Pennamen MD, et al.
Journal of the American Academy of Dermatology · 2018 · Letter
Chasset F, Arnaud L, Francès C
Contact dermatitis · 2018 · Case Reports
de Risi-Pugliese T, Amsler E, Collet E, Francès C, et al.
Acta dermato-venereologica · 2018 · Journal Article
Bohelay G, Blaise S, Levy P, Claeys A, et al.
Arthritis & rheumatology (Hoboken, N.J.) · 2023 · Journal Article
Barbhaiya M, Zuily S, Naden R, Hendry A, et al.
European heart journal. Cardiovascular Imaging · 2021 · Journal Article
Assan F, de Zuttere D, Bottin L, Tavolaro S, et al.
Arthritis care & research · 2021 · Journal Article
Barbhaiya M, Zuily S, Ahmadzadeh Y, Amigo MC, et al.